AR005642A1 - Compuestos antibioticos de cefalosporina, uso de los mismos para preparar composiciones farmaceuticas, dichas composiciones farmaceuticas que los comprenden,compuestos intermediarios de aplicacion en la preparacion de los primeros y metodo para elaborar dichos compuestos intermediarios - Google Patents

Compuestos antibioticos de cefalosporina, uso de los mismos para preparar composiciones farmaceuticas, dichas composiciones farmaceuticas que los comprenden,compuestos intermediarios de aplicacion en la preparacion de los primeros y metodo para elaborar dichos compuestos intermediarios

Info

Publication number
AR005642A1
AR005642A1 ARP960104714A ARP960104714A AR005642A1 AR 005642 A1 AR005642 A1 AR 005642A1 AR P960104714 A ARP960104714 A AR P960104714A AR P960104714 A ARP960104714 A AR P960104714A AR 005642 A1 AR005642 A1 AR 005642A1
Authority
AR
Argentina
Prior art keywords
preparation
pharmaceutical compositions
compositions
application
compounds
Prior art date
Application number
ARP960104714A
Other languages
English (en)
Original Assignee
Essential Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Essential Therapeutics Inc filed Critical Essential Therapeutics Inc
Publication of AR005642A1 publication Critical patent/AR005642A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Nuevos compuestos antibióticos de cefalosporina de fórmula (I) donde los sustituyentes tienen los valores indicados en la descripción. También seproponen composiciones farmacéuticas de aplicación para el tratamiento de infeccionesbacteriana s, especialmente de aquellas que son debidas a bacteriasresistentes a las beta-lactamas convencionales y, además la preparación de dichos antibióticos y compuestos intermediarios de aplicación en la preparaciónde dichos antibióticosy métodos de aplicación de dichos antibióticos para el tratamiento de infecciones bacterianas.
ARP960104714A 1995-10-12 1996-10-11 Compuestos antibioticos de cefalosporina, uso de los mismos para preparar composiciones farmaceuticas, dichas composiciones farmaceuticas que los comprenden,compuestos intermediarios de aplicacion en la preparacion de los primeros y metodo para elaborar dichos compuestos intermediarios AR005642A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US538995P 1995-10-12 1995-10-12

Publications (1)

Publication Number Publication Date
AR005642A1 true AR005642A1 (es) 1999-07-14

Family

ID=21715599

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960104714A AR005642A1 (es) 1995-10-12 1996-10-11 Compuestos antibioticos de cefalosporina, uso de los mismos para preparar composiciones farmaceuticas, dichas composiciones farmaceuticas que los comprenden,compuestos intermediarios de aplicacion en la preparacion de los primeros y metodo para elaborar dichos compuestos intermediarios

Country Status (28)

Country Link
US (4) US6057312A (es)
EP (1) EP0874854B1 (es)
JP (1) JPH11513670A (es)
KR (2) KR100491466B1 (es)
CN (3) CN1183142C (es)
AR (1) AR005642A1 (es)
AT (1) ATE210666T1 (es)
AU (1) AU708676B2 (es)
BR (1) BR9611062A (es)
CA (1) CA2234255A1 (es)
CZ (1) CZ108998A3 (es)
DE (1) DE69618015T2 (es)
DK (1) DK0874854T3 (es)
ES (1) ES2164924T3 (es)
HK (3) HK1017887A1 (es)
HU (1) HUP9802545A3 (es)
IL (1) IL123983A (es)
MX (1) MX9802891A (es)
MY (1) MY127641A (es)
NO (1) NO323007B1 (es)
NZ (1) NZ321135A (es)
PL (1) PL192069B1 (es)
PT (1) PT874854E (es)
RO (1) RO119830B1 (es)
SK (1) SK283524B6 (es)
TW (1) TW474935B (es)
WO (1) WO1997013772A2 (es)
ZA (1) ZA968617B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1295935B1 (it) 1997-10-30 1999-05-28 Acs Dobfar Spa Derivati aminotiazolici utili nella preparazione di antibiotici b -lattamici
US6159706A (en) * 1997-12-23 2000-12-12 Newbiotics, Inc. Application of enzyme prodrugs as anti-infective agents
AR029004A1 (es) * 1999-09-22 2003-06-04 Essential Therapeutics Inc Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana
US6723716B1 (en) * 1999-09-22 2004-04-20 Essential Therapeutics, Inc. 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof
US20030162762A1 (en) * 2000-07-07 2003-08-28 Chang-Seok Lee Novel cephalosporin compounds and process for preparing the same
CA2409329A1 (en) * 2000-07-07 2002-01-17 Lg Life Sciences Ltd. Novel cephalosporin compounds and process for preparing the same
US6599893B2 (en) * 2000-08-29 2003-07-29 Essential Therapeutics, Inc. Cephalosporin antibiotics and prodrugs thereof
AU2001245902B2 (en) * 2000-09-21 2007-08-23 Trine Pharmaceuticals, Inc. Prodrugs of a 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotic
AU2002234148A1 (en) 2000-12-29 2002-07-16 Bellsouth Intellectual Property Corporation Web based messaging system with personalized caller specific messages
US7119062B1 (en) 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
US6608196B2 (en) 2001-05-03 2003-08-19 Galileo Pharmaceuticals, Inc. Process for solid supported synthesis of pyruvate-derived compounds
ATE408593T1 (de) 2001-05-03 2008-10-15 Galileo Lab Inc Pyruvatderivate
KR20030071311A (ko) * 2002-02-28 2003-09-03 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조방법
AU2003240545A1 (en) * 2002-06-06 2003-12-22 Therapeutics Corporation Genome Use of ramoplanin to treat diseases associated with the use of antibiotics
AU2003274927A1 (en) * 2002-08-23 2004-03-11 Genome Therapeutics Corporation Methods and reagents for preventing bacteremias
US20050043223A1 (en) * 2003-04-25 2005-02-24 Leach Timothy S. Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility
CN107531660A (zh) 2015-03-13 2018-01-02 福马治疗股份有限公司 作为HDAC8抑制剂的α‑肉桂酰胺化合物和组合物
KR102408800B1 (ko) 2016-03-07 2022-06-13 머크 샤프 앤드 돔 코포레이션 비시클릭 아릴 모노박탐 화합물 및 박테리아 감염의 치료를 위한 그의 사용 방법
CN114671892B (zh) * 2022-04-24 2023-04-11 江苏海洋大学 含7-氨基头孢烷酸的1,3,4-噻二唑衍生物及制法与用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH605997A5 (es) * 1974-08-30 1978-10-13 Ciba Geigy Ag
US3992377A (en) * 1974-12-13 1976-11-16 Eli Lilly And Company 3-Thio-substituted cephalosporin antibiotics
FR2457297A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouvelles vinyl-3 cephalosporines, et leur preparation
FI801640A (fi) * 1979-05-23 1980-11-24 Rhone Poulenc Ind Nya tiovinyl-3 kefalosporiner deras framstaellning och dessa innehaollande kompositioner
FR2494274A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouvelles thiovinyl-3 cephalosporines, leur preparation et les medicaments qui les contiennent
GR79043B (es) * 1982-12-06 1984-10-02 Fujisawa Pharmaceutical Co
US4870168A (en) * 1987-02-26 1989-09-26 Bristol-Myers Company 3-Unsaturated alkyl cephems from 3-triflyl cephems
US5025006A (en) * 1990-06-26 1991-06-18 Merck & Co., Inc. 2-biphenyl-carbapenem antibacterial agents
US5077287A (en) * 1991-01-18 1991-12-31 Eli Lilly And Company 3-thiazolylthio carbacephem antibacterial agents
JPH05132488A (ja) * 1991-08-13 1993-05-28 Meiji Seika Kaisha Ltd 新規セフアロスポリン誘導体
TW427993B (en) * 1993-09-09 2001-04-01 Fujisawa Pharmaceutical Co New cephem compounds
EP0754184A1 (en) * 1994-04-01 1997-01-22 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics

Also Published As

Publication number Publication date
NO981653L (no) 1998-06-11
CN1179963C (zh) 2004-12-15
PL192069B1 (pl) 2006-08-31
KR20040047794A (ko) 2004-06-05
US6066630A (en) 2000-05-23
SK283524B6 (sk) 2003-09-11
HUP9802545A2 (hu) 1999-05-28
AU708676B2 (en) 1999-08-12
AU7441796A (en) 1997-04-30
MY127641A (en) 2006-12-29
NO323007B1 (no) 2006-12-18
ATE210666T1 (de) 2001-12-15
RO119830B1 (ro) 2005-04-29
SK46498A3 (en) 1998-10-07
KR19990064201A (ko) 1999-07-26
WO1997013772A3 (en) 1997-06-05
CN1183142C (zh) 2005-01-05
MX9802891A (es) 1998-09-30
WO1997013772A2 (en) 1997-04-17
HK1034191A1 (en) 2001-10-19
CN1291612A (zh) 2001-04-18
HUP9802545A3 (en) 2001-01-29
DE69618015D1 (de) 2002-01-24
US6057312A (en) 2000-05-02
KR100491466B1 (ko) 2005-05-25
TW474935B (en) 2002-02-01
DK0874854T3 (da) 2002-03-25
PL326150A1 (en) 1998-08-31
NZ321135A (en) 2000-01-28
ES2164924T3 (es) 2002-03-01
BR9611062A (pt) 1999-07-13
NO981653D0 (no) 1998-04-08
CN1291611A (zh) 2001-04-18
CA2234255A1 (en) 1997-04-17
CN1066735C (zh) 2001-06-06
CZ108998A3 (cs) 1998-07-15
EP0874854B1 (en) 2001-12-12
US6087355A (en) 2000-07-11
JPH11513670A (ja) 1999-11-24
US5859256A (en) 1999-01-12
PT874854E (pt) 2002-06-28
KR100455544B1 (ko) 2005-01-15
DE69618015T2 (de) 2002-05-16
CN1204336A (zh) 1999-01-06
EP0874854A2 (en) 1998-11-04
HK1034248A1 (en) 2001-10-19
ZA968617B (en) 1997-10-21
HK1017887A1 (en) 1999-12-03
IL123983A (en) 2007-03-08

Similar Documents

Publication Publication Date Title
AR005642A1 (es) Compuestos antibioticos de cefalosporina, uso de los mismos para preparar composiciones farmaceuticas, dichas composiciones farmaceuticas que los comprenden,compuestos intermediarios de aplicacion en la preparacion de los primeros y metodo para elaborar dichos compuestos intermediarios
BG103292A (en) 6-0-substituted ketolides possessing antibacterial effect
ES2131496T3 (es) Mejoras relativas a derivados glicopeptidicos.
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
EA199901014A1 (ru) C-4"-замещенные макролидные производные
PT1140993E (pt) Derivados de glicopeptidos e composicoes farmaceuticas contendo os mesmos
ATE349464T1 (de) Derivate von glykopeptidantibiotika
FI951468A (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
DK41193D0 (da) Ionkanalaabnere
BG104644A (en) Novel macrolides
EA200100623A1 (ru) Кетолидные антибиотики
ES2178037T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que los contienen.
PA8485601A1 (es) Azalidas de 13 miembros y su uso como agentes antibioticos.
EA199901016A1 (ru) 9-оксим-производные эритромицина
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
SE7611103L (sv) Forfarande for framstellning av 2-azetidinonforeningar
ES2193246T3 (es) Cefalosporinas antibacterianas.
DK0824539T3 (da) Dialkyltiacumicin-forbindelser
ES2161344T3 (es) Derivados oxazolin-amidicos basicos de los antibioticos ge2270 y similares.
AR021463A1 (es) Antibiotico de piridona con perfil de seguridad mejorado
CO4410328A1 (es) Compuestos que son derivados de los antibioticos macrolidos rosaramicina, repromicina, 5-micaminosiltilonolida, desmico- sina, lactenocina, o-desmetil-lactenocina, cirramicina a1, y 23-desoximicaminosiltilonolida
GT199600061A (es) Polimorfos de profarmaco de 6-n- (l-ala-l-ala)-trovafloxacina.
AR005136A1 (es) Compuestos antibioticos oligosacaridos hidrosolubles, una composicion farmaceutica que los contienen y el uso de los mismos para la preparacion de un medicamento
ES2076107B1 (es) Derivados de antibioticos macrolidos de anillos de 16 miembros.
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents

Legal Events

Date Code Title Description
FC Refusal